Jagsonpal Pharmaceuticals Ltd. announced it has entered into a definitive agreement to acquire an 85% equity stake in Aequitas Healthcare Private Limited. The strategic move marks Jagsonpal’s official entry into the institutional hospital segment, significantly expanding its footprint in India’s fast-growing healthcare ecosystem.
Based in Mumbai, Aequitas Healthcare is a specialized pharmaceutical company focused heavily on the marketing, sale, and distribution of pharmaceutical products directly to hospitals. Through this majority stake acquisition, Jagsonpal will leverage Aequitas’s robust, established institutional network and distribution capabilities to accelerate its corporate growth trajectory.
The acquisition aligns with Jagsonpal’s long-term vision to diversify its market reach and strengthen its presence across high-growth verticals within the Indian pharmaceutical industry. By tapping into the hospital channel, the company aims to address evolving healthcare demands and improve access to critical therapies.
The transaction is subject to customary closing conditions. Further details regarding the integration of operations and long-term synergy roadmaps will be shared in subsequent corporate disclosures.
Written by: Pragna Biswas
Graphics by: Pramit Hazra
